To perform the functional characterization of uterine cancer FBXW7 mutations using crispr technology.

Ended Purchase Order Awarded Last action

Contract number
HHSN268201700352A
Awardee
Awarding agency
Obligated
$53,310

Award facts

Opportunity
Contract value 100% obligated
$53,310.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
University City, MO 63130, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 -$840
Other Administrative Action P00002 -$15,048
Supplemental Agreement for work within scope 1 $4,086
Original award $65,112

About this award

The National Heart Lung and Blood Institute awarded a purchase order to The Washington University valued at $53,310 on September 22, 2017, to perform functional characterization of uterine cancer FBXW7 mutations using CRISPR technology. Performance occurs at the university's University City, Missouri location. The order carries a firm fixed price. Ultimate completion was scheduled for September 21, 2019.

Quick answers

Who was awarded contract HHSN268201700352A?

HHSN268201700352A was awarded to The Washington University by National Heart Lung and Blood Institute (National Institutes of Health) on September 22, 2017.

How much is contract HHSN268201700352A worth?

The government has obligated $53,310 on HHSN268201700352A.

Was contract HHSN268201700352A competed?

The extent of competition for HHSN268201700352A was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award